-
EDITORIAL
Pathways for the pharmaceutical industry to become more sustainable
J. Becker
-
COVER STORY
SK pharmateco – The pharma industry does not stand still… why should we?
-
APIS
Picking the perfect API partner post pandemic
T. Wilson
-
APIS
API manufacturing and environmental sustainability
G. Malhotra
-
COMPANY PROFILE
Angelini Pharma – An overview of the US pharma landscape
-
COLUMN: API OF THE MONTH
Mavacamten
R. Souza
-
COMPANY PROFILE
Faggi Enrico spa: Leading company in the precious metal field
-
COLUMN: CLINICAL TRIALS CHALLENGES
Real-world evidence in clinical research: challenges and opportunities
E. Comi
-
EXCIPIENTS
Qualifying the EXCiPACT GMP Certification Scheme as a provider of 3rd party audit reports and GMP Certificates
I. Moore
-
EXCIPIENTS
Excipient Sustainability – A user and a supplier perspective
R. Wood
-
ANALYTICAL TECHNOLOGIES
Streamlining analytical method development with a focus on genotoxic impurities – Developing analytical methods for a range of genotoxic impurities
M. Webberley
-
PAT
Sustainable, efficient manufacturing is driven by data – Key insights help you reduce the environmental footprint of your operations
M. Gadby
-
NEWS
-
CONTINUOUS MANUFACTURING
CPHI Annual Report: Continuous Manufacturing Will Alter the Drug Manufacturing Landscape a Decade from Now
B. Chatterjee
-
QUALITY & SUPPLY CHAIN SECURITY
Agile supply chain management and blockchain survey
A. Pesqueira
-
COLUMN: CUSTOMER BOND
CDMOs: Long on Tactical Supply Risk, Short on Strategic Planning for a Multipolar World Order – Pharma Outsourcing Best Practices Panel at CHEMSPEC Frankfurt, June 2022
B. Comanita
-
Column: REGULATION
Environmental Risk Assessment of Medicinal Products: a complex issue
A. Conto
-
A WORD WITH
Steve Morrison, Regulatory Manager – Atlantia Clinical Trials
-
A WORD WITH
Andrea Sentimenti, Marketing & Innovation Director – bormiolipharma
-
A WORD WITH
Christian Suà, CEO – Cerbios
-
A WORD WITH
Andrea Taborelli, Business Development and Licensing Manager – IBSA
-
A WORD WITH
Stefano Togni, Chief Commercial Officer – indena
-
A WORD WITH
Giorgio Bertolini, Senior Vice President Olon R&D – Olon
-
A WORD WITH
Enrico Zodio, CEO – Procos
-
PANEL DISCUSSION ON HPAPIs
-
EVENT
PREVIEW – CPhI Frankfurt 2022: At the Heart of Pharma
